OpenAlex
PricingAboutJobs
Log inGet started
Work

Anlotinib: First Global Approval

HTML

Year: 2018
Type: article
Source: Drugs
DOI: 10.1007/s40265-018-0939-x
Author: Yahiya Y. Syed
Institution: Springer Nature (New Zealand)
Language: English

Topic: Lung Cancer Treatments and Mutations
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: anlotinib, receptor tyrosine kinase inhibitors, non-small cell lung cancer, tumor angiogenesis, drug approval, oral small-molecule inhibitor, advanced cancer, sarcoma, carcinoma, clinical development
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2810290331
FWCI: 11.48
Cites: 17
Cited by: 278
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms